Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Real-world efficacy of inaticabtagene autoleucel in adult B-cell acute lymphoblastic leukemia patients with high-risk molecular alterations

Blood (2025) 146 (Supplement 1): 6865.

https://doi.org/10.1182/blood-2025-6865

Published: 2025

Journal Articles

Efficacy and safety profile of inaticabtagene autoleucel in Chinese adult patients with B-cell acute lymphoblastic leukemia who relapsed after their transplant: Insights from real-world data

Fen Zhou, Yuhua Li, Ying Wang, Xi Zhang, Jianmin Yang, Xiaobing Huang, JIN WANG, Xianmin Song, Xinsheng Xie, Li Wang, Jie Jin, Liye Zhong, Aibin Liang, Zhenyang Gu, Shengli Xue, Er-Lie Jiang, Baohong Ping, Heng Mei

Blood (2025) 146 (Supplement 1): 6859.

https://doi.org/10.1182/blood-2025-6859

Published: 2025

Journal Articles

Efficacy and safety profile of inaticabtagene autoleucel in Chinese patients with Philadelphia chromosome-positive b-ALL: Insights from real-world data

Blood (2025) 146 (Supplement 1): 6855.

https://doi.org/10.1182/blood-2025-6855

Published: 2025

Journal Articles

A real world study of inotuzumab ozogamicin for the treatment of B-cell acute lymphoblastic leukemia: Multi-center result from SH-ALL group

Yuchen Yan, Ligen Liu, Jie Hao, Xiaofeng Han, Ping Li, Libing Wang, Li Yang, Yong Tang, Cheng Wang, Weiyang Liu, Jiayi Ren, Jiong Hu, Jianmin Yang, Qi Zhu, Aibin Liang, Jian Hou, Xianmin Song, Jianqing Mi, JIN WANG

Blood (2025) 146 (Supplement 1): 6830.

https://doi.org/10.1182/blood-2025-6830

Published: 2025

Journal Articles

Effectiveness and safety profile of pola-based regimen in DLBCL Patients with high-risk factors in real world: A retrospective study in China

Shuyu Li, Jianmin Yang, Xiong Ni, Li Chen, Jie Chen, Libing Wang, Lei Gao, Lili Xu, Yang Wang, Ziwei Wang, Miaomiao Liu

Blood (2025) 146 (Supplement 1): 7222.

https://doi.org/10.1182/blood-2025-7222

Published: 2025

Journal Articles

Efficacy and safety profile of inaticabtagene autoleucel in Chinese patients with B-cell acute lymphoblastic leukemia: Insights from real-world data

Blood (2025) 146 (Supplement 1): 5122.

https://doi.org/10.1182/blood-2025-5122

Published: 2025

Journal Articles

Optimal Timing and Impact of Allogeneic Peripheral Blood Stem Cell Transplantation in Adult T-Cell Lymphoblastic Lymphoma: Insights from a Large Cohort Multi-Center Real-World Study in Shanghai

Fangfang Yu, Jiahua Niu, Jianmin Yang, Jian Hou, Siguo Hao, Aibin Liang, Hong Xiong, Qi Zhu, Ligen Liu, Jun Shi, Juan Du, Bobin Chen, Rong Wei, Wenli Zhao, Lihua Sun, Yunhua Hou, Rong Tao, Xianmin Song

Blood (2024) 144 (Supplement 1): 7818.

https://doi.org/10.1182/blood-2024-199964

Published: 2024

Journal Articles

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Blood (2024) 144 (Supplement 1): 2187.

https://doi.org/10.1182/blood-2024-206919

Published: 2024

Journal Articles

Real-World Outcomes of Zanubrutinib Monotherapy in Chronic Lymphocytic Leukemia: A Multicenter Retrospective Study

Jing Luo, Jiaojiao Zhang, Ligen Liu, Rong Wei, Yonghua Yao, Min Xu, Jie Xu, Jumei Shi, Jianmin Yang, Jian Hou, Jin Wang, Jian-Qing Mi

Blood (2023) 142 (Supplement 1): 6540.

https://doi.org/10.1182/blood-2023-180477

Published: 2023

Journal Articles

A Prediction Model for Early Recurrence after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with CMML: A Nationwide Representative Multicenter Study

Blood (2023) 142 (Supplement 1): 4951.

https://doi.org/10.1182/blood-2023-184407

Published: 2023

Journal Articles

A Risk Score Combined Clinical and Molecular Profiles Identifies a High-Risk Subgroup within Intermediate-Risk Acute Myeloid Leukemia

Xiaoxia Hu, Aijie Huang, Qi Chen, Ying Zhang, Lixia Liu, Chengcheng Wang, Weiping Zhang, Jianmin Yang, Jianmin Wang

Blood (2019) 134 (Supplement_1): 2713.

https://doi.org/10.1182/blood-2019-129186

Published: 2019

Journal Articles

SIRT3 Sumoylation Contributes to Chemoresistance in AML

Jiao MA, PhD, Bin Liu, MSc, Dan Yu, BSc, Wayne Tam, MD PhD, Jianmin Yang, PhD, Jinke Cheng, PhD

Blood (2018) 132 (Supplement 1): 3929.

https://doi.org/10.1182/blood-2018-99-110898

Published: 2018

Journal Articles

Minimal Residual Disease Monitored With Fluorescence In Situ Hybridization (FISH) In CD34 + CD38 - Population Predicts Clinical Outcome In Core Binding Factor Acute Myeloid Leukemia (CBF-AML)

Xiaoxia Hu, Libing Wang, Lei Gao, Sheng Xu, Shenglan Gong, Min Liu, Huiying Qiu, Xiaoqian Xu, Xiong Ni, Li Chen, Shuqing Lü, Jie Chen, Xianmin Song, Weiping Zhang, Jianmin Yang, Jianmin Wang, MD

Blood (2013) 122 (21): 1356.

https://doi.org/10.1182/blood.V122.21.1356.1356

Published: 2013

Journal Articles

FISH + CD34 + CD38 - Cells Detected In Newly Diagnosed Acute Myeloid Leukemia Patients Can Predict The Clinical Outcome

Libing Wang, Xiaoxia Hu, Lei Gao, Sheng Xu, Shenglan Gong, Li Chen, Shuqing Lü, Jie Chen, Huiying Qiu, Xiaoqian Xu, Xiong Ni, Xianmin Song, Weiping Zhang, Jianmin Yang, Min Liu, Jianmin Wang, MD

Blood (2013) 122 (21): 1379.

https://doi.org/10.1182/blood.V122.21.1379.1379

Published: 2013

Journal Articles

Bortezomib in Combination with Epirubicin, Dexamethasone and Thalidomide Is a Highly Effective Regimen for Multiple Myeloma

Shuqing Lü, Jianmin Wang, Xiaoqian Xu, Xiong Ni, Huiying Qiu, Yi He, Bin Wang, Chongmei Huang, Jianmin Yang

Blood (2008) 112 (11): 5201.

https://doi.org/10.1182/blood.V112.11.5201.5201

Published: 2008

Journal Articles

A Homoharringtonine-Based Protocol Is Superior to Daunorubicin and Idarubicin-Based Protocols in Elderly Patients with Newly-Diagnosed Acute Myeloid Leukemia with Comparable Effects and Low Toxicities: Experience in a Chinese Center.

Jianmin Wang, MD, Shuqing Lü, Jianmin Yang, Xianmin Song, Li Chen, Jun Hou, Weiping Zhang, Chongmei Huan, Xiong Ni, Huiying Qiu

Blood (2008) 112 (11): 1946.

https://doi.org/10.1182/blood.V112.11.1946.1946

Published: 2008

Journal Articles

Amplification and Mutation of PSMB5 Gene in Bortezomib Resistant Lymphoblastic Leukemia Cells Derived from Jurkat Line.

Shuqing Lu, MD, PhD, Jianmin Wang, MD, Jianmin Yang, MD/Ph.D, Shenglan Gong, MD, Hong Zhou, MD, Li Chen, MD/Ph.D, Xianmin Song, MD/Ph.D

Blood (2007) 110 (11): 2373.

https://doi.org/10.1182/blood.V110.11.2373.2373

Published: 2007

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Real-world efficacy of inaticabtagene autoleucel in adult B-cell acute lymphoblastic leukemia patients with high-risk molecular alterations

Efficacy and safety profile of inaticabtagene autoleucel in Chinese adult patients with B-cell acute lymphoblastic leukemia who relapsed after their transplant: Insights from real-world data

Efficacy and safety profile of inaticabtagene autoleucel in Chinese patients with Philadelphia chromosome-positive b-ALL: Insights from real-world data

A real world study of inotuzumab ozogamicin for the treatment of B-cell acute lymphoblastic leukemia: Multi-center result from SH-ALL group

Effectiveness and safety profile of pola-based regimen in DLBCL Patients with high-risk factors in real world: A retrospective study in China

Efficacy and safety profile of inaticabtagene autoleucel in Chinese patients with B-cell acute lymphoblastic leukemia: Insights from real-world data

Optimal Timing and Impact of Allogeneic Peripheral Blood Stem Cell Transplantation in Adult T-Cell Lymphoblastic Lymphoma: Insights from a Large Cohort Multi-Center Real-World Study in Shanghai

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Real-World Outcomes of Zanubrutinib Monotherapy in Chronic Lymphocytic Leukemia: A Multicenter Retrospective Study

A Prediction Model for Early Recurrence after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with CMML: A Nationwide Representative Multicenter Study

A Risk Score Combined Clinical and Molecular Profiles Identifies a High-Risk Subgroup within Intermediate-Risk Acute Myeloid Leukemia

SIRT3 Sumoylation Contributes to Chemoresistance in AML

Minimal Residual Disease Monitored With Fluorescence In Situ Hybridization (FISH) In CD34 + CD38 - Population Predicts Clinical Outcome In Core Binding Factor Acute Myeloid Leukemia (CBF-AML)

FISH + CD34 + CD38 - Cells Detected In Newly Diagnosed Acute Myeloid Leukemia Patients Can Predict The Clinical Outcome

Bortezomib in Combination with Epirubicin, Dexamethasone and Thalidomide Is a Highly Effective Regimen for Multiple Myeloma

A Homoharringtonine-Based Protocol Is Superior to Daunorubicin and Idarubicin-Based Protocols in Elderly Patients with Newly-Diagnosed Acute Myeloid Leukemia with Comparable Effects and Low Toxicities: Experience in a Chinese Center.

Amplification and Mutation of PSMB5 Gene in Bortezomib Resistant Lymphoblastic Leukemia Cells Derived from Jurkat Line.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only